Transdiagnostic Therapy Eases Body Image Worries in Teens, Trial Finds

For teenagers gripped by an obsessive sense that some part of their appearance is flawed, the world can shrink to the size of a mirror. Body dysmorphic disorder, a condition marked by intrusive preoccupations with perceived defects that others barely notice or cannot see at all, often takes root during adolescence, precisely the developmental window when identity and social belonging feel most fragile. A new randomized clinical trial from Iran, published in Annals of General Psychiatry, offers fresh evidence that a transdiagnostic form of cognitive-behavioral therapy can meaningfully reduce the core symptoms of this condition in young people whose concerns have not yet crossed the full clinical threshold, while also revealing the limits of a single treatment approach when it comes to the depression that so often shadows the disorder.

The study, led by Seyedeh Elnaz Mousavi of the Social Determinants of Health Research Center at Zanjan University of Medical Sciences together with colleagues from several Iranian institutions, focused on a population that clinicians frequently see but rarely study in isolation: adolescents with subclinical body dysmorphic disorder. These are young people whose appearance-related distress is real and impairing but falls just short of the formal diagnostic cutoff. The researchers recruited 62 participants aged 12 to 18 years in Zanjan, each of whom met the study’s operational definition of subclinical BDD, namely a Clinical Severity Rating of 2 or 3 on the Anxiety Disorders Interview Schedule for Children, a structured diagnostic instrument. A rating in that range signals clinically meaningful distress below the threshold of 4 that typically denotes a full disorder, making this group a natural target for early intervention aimed at preventing progression.

What distinguishes this trial from much of the existing treatment literature is its choice of therapeutic framework. Rather than deploying a protocol designed specifically for body dysmorphic disorder, the team tested the Unified Protocol for Adolescents, known as UP-A, a transdiagnostic cognitive-behavioral treatment built on the premise that emotional disorders share common underlying mechanisms. The UP-A targets neuroticism, aversive reactivity to emotions, and maladaptive emotion regulation strategies rather than the surface symptoms of any single diagnosis. In this trial, the twelve-session intervention was delivered entirely online, a delivery mode with obvious practical advantages for reaching adolescents who may be reluctant to attend in-person mental health services or who live far from specialized clinics.

The design was a parallel-group superiority trial with a 1:1 allocation ratio. Half of the participants were randomly assigned to the UP-A intervention and half to a waitlist control group, which received educational pamphlets after the assessment phase. Evaluations took place at three time points: baseline, immediately after the two-month intervention period, and again at six-month follow-up. The researchers measured four domains using validated instruments: self-focused attention with the Focus of Attention Questionnaire, dysmorphic concerns with the Dysmorphic Concerns Questionnaire, depressive symptoms with the Hamilton Depression Rating Scale, and social adjustment with the relevant subscale of the Adjustment Inventory for School Students. Statistical analysis relied on marginal longitudinal models, which can track change over time within individuals while formally testing differences between groups.

The headline result is striking in its clarity. Adolescents who completed the UP-A program showed significantly greater reductions in both self-focused attention and BDD symptoms compared with their waitlisted peers, and these between-group advantages held at both the post-test assessment and the six-month follow-up, with statistical significance at the conventional threshold of P less than 0.05. Self-focused attention, the habitual tendency to direct attention inward toward one’s own perceived flaws and bodily sensations, is considered a core maintaining mechanism across the emotional disorders, and its reduction is precisely what the Unified Protocol is engineered to accomplish. The durability of these gains six months after the final session suggests that the skills taught in the protocol, which include mindful emotion awareness, cognitive flexibility, and countering avoidance behaviors, were not merely palliative but were internalized by the participants.

The picture for social adjustment was more nuanced. The marginal longitudinal model detected a significant group-by-time interaction at post-test, with a beta coefficient of negative 1.83 and a P value below 0.001, indicating an acute improvement in social functioning within the intervention group. Yet when the researchers compared the two groups directly at the post-test time point, the difference did not reach statistical significance, with a P value of 0.29, and the same held true at the six-month follow-up, where the P value was 0.40. The authors interpret this pattern as evidence of gradual improvement in social adjustment rather than an immediate and decisive separation between the treated and untreated groups. In practical terms, the therapy appears to set adolescents on a positive trajectory in their social lives, but that trajectory takes time to diverge clearly from what happens among untreated peers.

Depression proved the most stubborn target. Within the intervention group, depressive symptoms as measured by the Hamilton scale did improve significantly over the course of the study, a within-group change that reached statistical significance. However, when the treated adolescents were compared against the waitlist controls, the between-group differences were not statistically significant either at post-test, where the P value was 0.34, or at follow-up, where it was 0.11. In other words, some of the improvement in mood observed among treated participants may have reflected the passage of time, natural remission, or nonspecific factors such as receiving attention and completing assessments, rather than the specific effects of the UP-A protocol itself. The trial’s authors are candid about this limitation, concluding that the specific clinical efficacy of the intervention in reducing comorbid depressive symptoms beyond waitlist and temporal effects was not supported by their data.

This mixed outcome carries real clinical weight. Body dysmorphic disorder rarely travels alone; it is frequently accompanied by major depression, social anxiety, and suicidal ideation, and the presence of comorbid depression is one of the strongest predictors of poor outcomes. A treatment that reliably dismantles the appearance preoccupation and the self-focused attention that fuels it, but that leaves depressive symptoms largely untouched, is a partial victory. The authors themselves emphasize the need for targeted clinical monitoring of depressive symptoms in this population, a recommendation that effectively argues for a stepped or combined care model in which transdiagnostic therapy addresses the core BDD mechanisms while depression is assessed and, when necessary, treated with adjunctive approaches.

The trial also contributes to a broader and increasingly urgent conversation about early intervention. Subclinical presentations of body dysmorphic disorder are common in adolescence, and a substantial proportion of affected individuals go on to develop the full disorder, which is associated with hospitalization, cosmetic surgery seeking, and elevated suicide risk. Intervening at the subclinical stage, before rigid rituals such as mirror checking and camouflaging become entrenched, could alter the natural history of the condition. The fact that a scalable, online, twelve-session protocol produced durable reductions in dysmorphic concerns among this age group is therefore significant for public health planning, particularly in settings where specialized BDD clinics are scarce. The online delivery format tested here could, in principle, be extended to school-based screening and intervention programs.

Certain caveats deserve attention when weighing the findings. The control condition was a waitlist rather than an active comparison treatment, which means the trial cannot establish whether the UP-A outperforms disorder-specific CBT or other structured psychological interventions; it demonstrates efficacy relative to no treatment. The sample of 62 participants, while adequate for the primary comparisons, limits the precision of estimates for secondary outcomes such as depression and social adjustment, where the observed differences hovered near the significance boundary. All participants were drawn from a single Iranian city, and cultural factors shaping body image concerns may influence generalizability. The trial was registered in the Iranian Registry of Clinical Trials and received no external funding, and the authors declared no competing interests. Even with these limitations, the study stands as one of the few randomized tests of a transdiagnostic approach in adolescents with body image pathology, and its central message is likely to resonate with clinicians: treating the shared emotional mechanisms underlying distress can quiet the mirror-obsessed mind of a struggling teenager, but the darkness of comorbid depression may require its own deliberate light.

Subject of Research: Transdiagnostic cognitive-behavioral therapy for adolescents with subclinical body dysmorphic disorder

Article Title: Effect of transdiagnostic therapy on psychological variables and symptoms of adolescents with sub-clinical body dysmorphic disorder: a randomized clinical trial

Article References: Mousavi, S. E., Sarani Yaztappeh, J., Kalke, Y. M., Saed, O., & Javadi, V. (2026). Effect of transdiagnostic therapy on psychological variables and symptoms of adolescents with sub-clinical body dysmorphic disorder: a randomized clinical trial. Annals of General Psychiatry. https://doi.org/10.1186/s12991-026-00696-9

Image Credits: AI Generated

DOI: 10.1186/s12991-026-00696-9

Keywords: body dysmorphic disorder, adolescents, transdiagnostic therapy, Unified Protocol, cognitive behavioral therapy, self-focused attention, social adjustment, depressive symptoms, randomized clinical trial, mental health, Effect, transdiagnostic